Stock listing
Munich:ON4 ONO Pharmaceutical Co., Ltd. Aktie
German listing (Munich) of ONO Pharmaceutical Co., Ltd. · home listing Tokyo:4528
Follow ONO Pharmaceutical Co., Ltd. into a list and get an email when it puts out news.
Share price · MUN:ON4
€13.72 EUR -0.65 (-4.6%)
Close on Nov 20, 2026
- Day range
- €13.72 – €14.05 EURNov 20, 2026
- Market cap
- €6.44B EURAt the close on Nov 20, 2026 · price × 469.9M shares outstanding
- 52-week range
- €11.39 – €14.56 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- €0 EURMedian day 0 shares · 57 days with no trades · last 3 months, Aug 20, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| OTC:OPHLY | $5.14 USD | +0.01 (+0.2%) | 200 | $5.22 | $5.22 | $5.14 | $5.13 | Close on Nov 20, 2026 |
| Frankfurt:ON4 | €13.47 EUR | -0.13 (-1.0%) | — | €13.44 | €13.47 | €13.44 | €13.60 | Close on Nov 20, 2026 |
| Munich:ON4 | €13.72 EUR | -0.655 (-4.6%) | — | €14.05 | €14.05 | €13.72 | €14.37 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 6, 2026 · MUN:ON4 · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €13.26 | -0.744 | -5.3% | €13.26 | €13.26 | €13.26 | 0 | |
| €14.01 | +0.567 | +4.2% | €14.01 | €14.01 | €14.01 | 0 | |
| €13.44 | +0.456 | +3.5% | €13.47 | €13.47 | €13.44 | 0 | |
| €12.99 | +0.109 | +0.8% | €12.99 | €13.00 | €12.96 | 0 | |
| €12.88 | +0.014 | +0.1% | €12.98 | €12.98 | €12.85 | 0 | |
| €12.86 | +0.399 | +3.2% | €12.86 | €12.86 | €12.86 | 0 | |
| €12.46 | -1.701 | -12.0% | €12.67 | €12.69 | €12.42 | 0 | |
| €14.16 | +0.194 | +1.4% | €14.16 | €14.16 | €14.16 | 0 | |
| €13.97 | -0.185 | -1.3% | €13.97 | €14.05 | €13.95 | 0 | |
| €14.16 | -0.008 | -0.1% | €14.16 | €14.16 | €14.16 | 0 | |
| €14.16 | +0.044 | +0.3% | €14.16 | €14.16 | €14.16 | 0 | |
| €14.12 | +0.131 | +0.9% | €14.12 | €14.12 | €14.12 | 0 | |
| €13.99 | +0.203 | +1.5% | €13.99 | €13.99 | €13.99 | 0 | |
| €13.79 | +0.087 | +0.6% | €13.77 | €13.88 | €13.67 | 0 | |
| €13.70 | +0.103 | +0.8% | €13.70 | €13.70 | €13.70 | 0 | |
| €13.60 | +0.402 | +3.0% | €13.61 | €13.65 | €13.55 | 0 | |
| €13.19 | +0.384 | +3.0% | €13.19 | €13.20 | €13.19 | 0 | |
| €12.81 | -0.123 | -1.0% | €12.84 | €12.87 | €12.77 | 0 | |
| €12.93 | +0.23 | +1.8% | €12.93 | €12.93 | €12.93 | 0 | |
| €12.70 | +0.025 | +0.2% | €12.70 | €12.70 | €12.70 | 0 | |
| €12.68 | -0.001 | 0.0% | €12.68 | €12.68 | €12.68 | 0 | |
| €12.68 | -0.148 | -1.2% | €12.68 | €12.68 | €12.68 | 0 | |
| €12.83 | +0.045 | +0.4% | €12.83 | €12.83 | €12.83 | 0 | |
| €12.78 | +0.023 | +0.2% | €12.78 | €12.78 | €12.78 | 0 | |
| €12.76 | -0.232 | -1.8% | €12.80 | €12.80 | €12.74 | 0 | |
| €12.99 | +0.004 | 0.0% | €13.00 | €13.08 | €12.93 | 0 | |
| €12.99 | -0.007 | -0.1% | €12.99 | €12.99 | €12.99 | 0 | |
| €12.99 | -0.153 | -1.2% | €12.99 | €12.99 | €12.99 | 0 | |
| €13.15 | -0.262 | -2.0% | €13.16 | €13.19 | €12.97 | 0 | |
| €13.41 | -0.134 | -1.0% | €13.56 | €13.62 | €13.38 | 0 | |
| €13.54 | +0.125 | +0.9% | €13.47 | €13.54 | €13.42 | 0 | |
| €13.42 | +0.01 | +0.1% | €13.42 | €13.42 | €13.42 | 0 | |
| €13.41 | +0.206 | +1.6% | €13.41 | €13.41 | €13.41 | 0 | |
| €13.20 | +0.067 | +0.5% | €13.20 | €13.20 | €13.20 | 0 | |
| €13.13 | -0.124 | -0.9% | €13.23 | €13.38 | €13.12 | 0 | |
| €13.26 | -0.056 | -0.4% | €13.26 | €13.26 | €13.26 | 0 | |
| €13.31 | +0.297 | +2.3% | €13.33 | €13.33 | €13.31 | 0 | |
| €13.02 | -0.196 | -1.5% | €13.02 | €13.02 | €13.02 | 0 | |
| €13.21 | +0.067 | +0.5% | €13.27 | €13.27 | €13.06 | 0 | |
| €13.15 | +0.164 | +1.3% | €13.20 | €13.21 | €12.96 | 0 | |
| €12.98 | -0.24 | -1.8% | €12.98 | €13.07 | €12.93 | 0 | |
| €13.22 | -0.075 | -0.6% | €13.22 | €13.24 | €13.21 | 0 | |
| €13.30 | -0.115 | -0.9% | €13.30 | €13.31 | €13.27 | 0 | |
| €13.41 | -0.11 | -0.8% | €13.41 | €13.41 | €13.41 | 0 | |
| €13.52 | +0.014 | +0.1% | €13.37 | €13.54 | €13.25 | 0 | |
| €13.51 | -0.161 | -1.2% | €13.51 | €13.51 | €13.43 | 0 | |
| €13.67 | +0.307 | +2.3% | €13.62 | €13.81 | €13.54 | 0 | |
| €13.36 | -0.083 | -0.6% | €13.40 | €13.40 | €13.34 | 0 | |
| €13.45 | +0.26 | +2.0% | €13.47 | €13.54 | €13.35 | 0 | |
| €13.19 | -0.061 | -0.5% | €13.17 | €13.25 | €13.17 | 0 | |
| €13.25 | +0.02 | +0.2% | €13.26 | €13.28 | €13.25 | 0 | |
| €13.23 | -0.147 | -1.1% | €13.21 | €13.24 | €13.18 | 0 | |
| €13.37 | +0.088 | +0.7% | €13.47 | €13.48 | €13.36 | 0 | |
| €13.29 | +0.182 | +1.4% | €13.28 | €13.32 | €13.27 | 0 | |
| €13.10 | -0.025 | -0.2% | €13.11 | €13.11 | €13.10 | 0 | |
| €13.13 | -0.289 | -2.2% | €13.06 | €13.13 | €13.04 | 0 | |
| €13.42 | +0.159 | +1.2% | €13.42 | €13.42 | €13.42 | 0 |
Splits
1 split · MUN:ON4 · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 5-for-1 | Split |
- Ticker
- Munich:ON4
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- Munich
- Currency
- EUR
What changed lately
Latest news release · Oct 29, 2026
Consolidated Financial Results for the Second Quarter of Fiscal Year Ending March 31, 2027 (IFRS)
Latest deck · Oct 29, 2026
Q2 FY2027 Earnings Presentation
Earnings · 48 slides
Latest news
Consolidated Financial Results for the Second Quarter of Fiscal Year Ending March 31, 2027 (IFRS)
Oct 28, 2026
Closed €12.46 (-12.0%) on Oct 29, 2026
2nd Quarter of Fiscal Year 2026 (Ending March 31, 2027) (April 1, 2026 to September 30, 2026) Supplementary Materials (Consolidated IFRS)
Oct 28, 2026
Closed €12.46 (-12.0%) on Oct 29, 2026
ONO Pharmaceutical: Pharma Announces an Exclusive License Agreement with Biohaven to Develop and Commercialize IgG Degraders in Japan, South Korea, Taiwan, and ASEAN Countries
Oct 8, 2026
Closed €12.68 (-1.2%) on Oct 8, 2026
Ono Pharma Announces an Exclusive License Agreement with Biohaven to Develop and Commercialize IgG Degraders in Japan, South Korea, Taiwan, and ASEAN
Oct 8, 2026
Closed €12.68 (-1.2%) on Oct 8, 2026
ONO Pharmaceutical: Received Manufacturing and Marketing Approval in Japan for XCOPRI® Tablets for the Treatment of Patients with Partial-onset Seizures, With or Without Secondary Generalized Seizures
Sep 16, 2026
Closed €13.02 (-1.5%) on Sep 16, 2026
Kaneka Ubiquinol™ memenangi nutraingredients Asia Ingredient of the Year: healthspan Award 2026
Sep 8, 2026
Closed €13.30 (-0.9%) on Sep 9, 2026
Issued by another party
OPDIVO® Intravenous Infusion Approved in Taiwan for the Treatment of Resectable Non-Small Cell Lung Cancer with Neoadjuvant OPDIVO in Combination with Chemotherapy Followed by Surgery and Adjuvant Single-Agent OPDIVO
Aug 19, 2026
Closed €13.26 (+0.5%) on Aug 19, 2026
ONO Pharmaceutical: Continues to be Selected for ESG Investment Indexes Adopted by GPIF
Aug 17, 2026
Closed €13.04 (-0.9%) on Aug 17, 2026
Consolidated Financial Results for the First Quarter of Fiscal Year Ending March 31, 2027 (IFRS)
Jul 30, 2026
Closed €12.92 (-1.2%) on Jul 31, 2026
ONO Pharmaceutical Co., Ltd. on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 30 in the last 12 months · 40 in all · newest Oct 29, 2026 · oldest 2025
- Decks
- 39 decks · latest Oct 29, 2026
Where ONO Pharmaceutical Co., Ltd. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Tokyo:4528 小野薬品工業 · Home listing | Tokyo | Japan | JPY |
| OTC:OPHLY | OTC | United States | USD |
| LS Exchange:859650 | LS Exchange | Germany | EUR |
| Lang & Schwarz:859650 | Lang & Schwarz | Germany | EUR |
| BMV:4528N | BMV | Mexico | MXN |
| gettex:ON4 | gettex | Germany | EUR |
| OTC:OPHLF | OTC | United States | USD |
| Dusseldorf:ON4 | Dusseldorf | Germany | EUR |
| Frankfurt:ON4 | Frankfurt | Germany | EUR |
| BIVA:4528N | BIVA | Mexico | MXN |
| gettex:ON40 | gettex | Germany | EUR |
| Lang & Schwarz:A2N6NC | Lang & Schwarz | Germany | EUR |
| Munich:ON4 · This page | Munich | Germany | EUR |
| Munich:ON40 | Munich | Germany | EUR |
| Stuttgart:ON4 | Stuttgart | Germany | EUR |
| Tradegate:ON4 | Tradegate | Germany | EUR |
| Hamburg:ON4 | Hamburg | Germany | EUR |
| Hanover:ON4 | Hanover | Germany | EUR |
Team and board
| Officer | Role |
|---|---|
| Ono Pharmaceutical Co | Corporate Communications |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q2 FY2027 Earnings Presentation | Earnings | 48 slides | Oct 29, 2026 |
| Q1 FY2027 Earnings Presentation | Earnings | 31 slides | Jul 31, 2026 |
| Investor Day (June 2026) | Investor day | 61 slides | Jun 8, 2026 |
| Investor Day (June 2026) | Investor day | 61 slides | Jun 8, 2026 |
| FY2025 Earnings Presentation | Earnings | 48 slides | May 8, 2026 |
| ESG Presentation (March 2026) | Sustainability | 31 slides | Mar 24, 2026 |
| Investor Day (March 2026) | Investor day | 31 slides | Mar 24, 2026 |
| Q3 FY2025 Earnings Presentation | Earnings | 36 slides | Feb 2, 2026 |
| 44th Annual J.P. Morgan Healthcare Conference (January 2026) | Conference | 30 slides | Jan 14, 2026 |
| Q2 FY2025 Earnings Presentation | Earnings | 54 slides | Oct 30, 2025 |
All 39 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q1 FY2025 Earnings Presentation | Earnings | 37 slides | Aug 1, 2025 |
| Investor Presentation (June 2025) | Investor deck | 9 slides | Jun 19, 2025 |
| Investor Day (June 2025) | Investor day | 15 slides | Jun 4, 2025 |
| Investor Day (May 2025) | Investor day | 39 slides | May 20, 2025 |
| FY2024 Earnings Presentation | Earnings | 44 slides | May 8, 2025 |
| ESG Presentation (March 2025) | Sustainability | 34 slides | Mar 5, 2025 |
| ESG Presentation (March 2025) | Sustainability | 34 slides | Mar 5, 2025 |
| Q3 FY2024 Earnings Presentation | Earnings | 46 slides | Feb 3, 2025 |
| Q2 FY2024 Earnings Presentation | Earnings | 51 slides | Nov 1, 2024 |
| Q1 FY2024 Earnings Presentation | Earnings | 35 slides | Jul 31, 2024 |
| FY2023 Earnings Presentation | Earnings | 40 slides | May 10, 2024 |
| Merger or Acquisition (April 2024) | Merger or acquisition | 27 slides | Apr 30, 2024 |
| Merger or Acquisition (April 2024) | Merger or acquisition | 27 slides | Apr 30, 2024 |
| ESG Presentation (March 2024) | Sustainability | 47 slides | Mar 26, 2024 |
| ESG Presentation (March 2024) | Sustainability | 47 slides | Mar 26, 2024 |
| Technical Presentation (February 2024) | Technical | 65 slides | Feb 22, 2024 |
| Investor Day (February 2024) | Investor day | 65 slides | Feb 22, 2024 |
| ESG Presentation (March 2023) | Sustainability | 48 slides | Mar 28, 2023 |
| ESG Presentation (March 2023) | Sustainability | 48 slides | Mar 28, 2023 |
| Technical Presentation (February 2023) | Technical | 51 slides | Feb 24, 2023 |
| Technical Presentation (February 2023) | Technical | 51 slides | Feb 24, 2023 |
| ESG Presentation (March 2022) | Sustainability | 44 slides | Mar 28, 2022 |
| ESG Presentation (March 2022) | Sustainability | 44 slides | Mar 28, 2022 |
| Technical Presentation (September 2021) | Technical | 31 slides | Sep 7, 2021 |
| Technical Presentation (September 2021) | Technical | 31 slides | Sep 7, 2021 |
| ESG Presentation (March 2021) | Sustainability | 42 slides | Mar 22, 2021 |
| ESG Presentation (March 2021) | Sustainability | 42 slides | Mar 22, 2021 |
| ESG Presentation (March 2020) | Sustainability | 50 slides | Mar 24, 2020 |
| ESG Presentation (March 2020) | Sustainability | 50 slides | Mar 24, 2020 |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| Consolidated Financial Results for the Second Quarter of Fiscal Year Ending March 31, 2027 (IFRS) | Oct 28, 2026 | Results | Tokyo Stock Exchange |
| 2nd Quarter of Fiscal Year 2026 (Ending March 31, 2027) (April 1, 2026 to September 30, 2026) Supplementary Materials (Consolidated IFRS) | Oct 28, 2026 | Results | Tokyo Stock Exchange |
| Ono Pharma Announces an Exclusive License Agreement with Biohaven to Develop and Commercialize IgG Degraders in Japan, South Korea, Taiwan, and ASEAN | Oct 8, 2026 | Acquisition or disposal | Tokyo Stock Exchange |
| Consolidated Financial Results for the First Quarter of Fiscal Year Ending March 31, 2027 (IFRS) | Jul 30, 2026 | Results | Tokyo Stock Exchange |
Cap table
Built by 6ix from ONO Pharmaceutical Co., Ltd.’s releases
- Common shares
- 498,692,800
- Fully diluted
- 498,692,800
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 498,692,800 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 498,692,800 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Ono Pharmaceutical Co | Corporate Communications · Since at least May 27, 2026 |
Log in to ask 6ix AI your own questions about ONO Pharmaceutical Co., Ltd.